Targets › PPTN
1 program from 1 company in 1 trial: 1 Phase 2; Other.
Open in Phaseline: the race on PPTN, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| Albert Einstein Healthcare Network | EnvarsusXR Extended-release tacrolimus formulation | PPTN | Phase 2 | Post Liver Transplant | – |
Post Liver Transplant (1)
small molecule (1)
Albert Einstein Healthcare Network (1)
–
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.